Table 3.
Substrate | FMO | Km (μM) | Product | Reference |
---|---|---|---|---|
Sulfur-containing | ||||
Cysteamine | pFMO1a | 120 | Disulfide | Poulsen, 1981 |
hFMO2 | 175 | Unpublished | ||
S-cysteine conjugates | pFMO1 | 344–1538 | S-oxide (diastereometric excess 10–78%) | Park et al., 1992 |
S-allyl-l-cysteine | Rat in vivo | Sulfoxide | Krause et al., 2002 | |
S-farnesylcysteine and | pFMO1 | Park et al., 1994 | ||
S-farnesylcysteine methyl ester | 23–34 | S-oxide | Park et al., 1994 | |
Dihydrolipoic acid and | pFMO1 | 1700 | Taylor & Ziegler, 1987 | |
Lipoic acid | pFMO1 | 120 | Taylor & Ziegler, 1987 | |
hFMO2 | 71 | Unpublished | ||
Methionine | hFMO3 | 20,000 | (d>l)-sulfoxide | Ripp et al., 1999 |
rat FMO3 | 3400 | (d>l)-sulfoxide | Krause et al., 1996 | |
Rabbit FMO1 | 48,000 | (d/l=1.5)-sulfoxide | Duescher et al., 1994 | |
Rabbit FMO2 | 30,000 | (d/l=0.7)-sulfoxide | ||
Rabbit FMO3 | 6500 | (d/l=8)-sulfoxide | ||
Nitrogen-containing | ||||
Trimethylamine | hFMO3 | 28 | N-oxide | Lang et al., 1998 |
pFMO1 | 617 | Sabourin & Hodgson, 1984 | ||
Mouse liver FMO | 2340 | Sabourin & Hodgson, 1984 |
p = Pig; h = human.